NO20015397L - 1,5-Benzodiazepin-derivater - Google Patents

1,5-Benzodiazepin-derivater

Info

Publication number
NO20015397L
NO20015397L NO20015397A NO20015397A NO20015397L NO 20015397 L NO20015397 L NO 20015397L NO 20015397 A NO20015397 A NO 20015397A NO 20015397 A NO20015397 A NO 20015397A NO 20015397 L NO20015397 L NO 20015397L
Authority
NO
Norway
Prior art keywords
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Application number
NO20015397A
Other languages
English (en)
Other versions
NO20015397D0 (no
Inventor
David Colclough
Anne Hodgson
Jerzy Ryszard Szewczyk
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20015397L publication Critical patent/NO20015397L/no
Publication of NO20015397D0 publication Critical patent/NO20015397D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015397A 1999-05-06 2001-11-05 1,5-Benzodiazepin-derivater NO20015397D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process
PCT/EP2000/003982 WO2000068209A2 (en) 1999-05-06 2000-05-04 1,5-benzodiazepine derivatives as cck-a receptor agonists

Publications (2)

Publication Number Publication Date
NO20015397L true NO20015397L (no) 2001-11-05
NO20015397D0 NO20015397D0 (no) 2001-11-05

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015397A NO20015397D0 (no) 1999-05-06 2001-11-05 1,5-Benzodiazepin-derivater

Country Status (21)

Country Link
EP (1) EP1212305A2 (no)
JP (1) JP2002544200A (no)
KR (1) KR20020012567A (no)
CN (1) CN1161345C (no)
AR (1) AR022044A1 (no)
AU (1) AU4754800A (no)
BR (1) BR0010338A (no)
CA (1) CA2370801A1 (no)
CO (1) CO5170461A1 (no)
CZ (1) CZ20013988A3 (no)
HK (1) HK1046138A1 (no)
HU (1) HUP0201181A3 (no)
IL (1) IL146124A0 (no)
MX (1) MXPA01011267A (no)
MY (1) MY138319A (no)
NO (1) NO20015397D0 (no)
NZ (1) NZ515048A (no)
PE (1) PE20010110A1 (no)
PL (1) PL351546A1 (no)
TR (1) TR200103169T2 (no)
WO (1) WO2000068209A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
UA84208C2 (en) 2004-05-25 2008-09-25 Пфайзер Продактс Инк. Tetraazabenzo(e)azulene derivatives and analogs thereof
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
CZ20013988A3 (cs) 2002-02-13
MXPA01011267A (es) 2002-05-06
CA2370801A1 (en) 2000-11-16
TR200103169T2 (tr) 2002-04-22
JP2002544200A (ja) 2002-12-24
WO2000068209A3 (en) 2001-03-01
CO5170461A1 (es) 2002-06-27
KR20020012567A (ko) 2002-02-16
HUP0201181A2 (hu) 2002-12-28
IL146124A0 (en) 2002-07-25
MY138319A (en) 2009-05-29
PE20010110A1 (es) 2001-03-05
CN1362949A (zh) 2002-08-07
AR022044A1 (es) 2002-09-04
HUP0201181A3 (en) 2003-10-28
NO20015397D0 (no) 2001-11-05
BR0010338A (pt) 2002-02-13
WO2000068209A2 (en) 2000-11-16
PL351546A1 (en) 2003-05-05
HK1046138A1 (zh) 2002-12-27
CN1161345C (zh) 2004-08-11
EP1212305A2 (en) 2002-06-12
AU4754800A (en) 2000-11-21
NZ515048A (en) 2004-01-30

Similar Documents

Publication Publication Date Title
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
MA26831A1 (fr) Derives de benzodiazepine."
MA26832A1 (fr) Derives de benzodiazepine.
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
BR0011566B1 (pt) bolsa flexìvel.
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
ID26743A (id) Turunan 1,2,4,5-tetrahidro-benzo [d] azepin
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NO20010193L (no) Tiobenzimidazol-derivater
DK0930302T3 (da) Benzosulfonderivater
NO20010514D0 (no) Aminometylkarboksylsyre-derivater
ATE259810T1 (de) Phenyl-xanthinderivate
MA26794A1 (fr) Derives de 5-phenyl-pyrimidine.
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
NO20003825L (no) 1,3,4 - oxadiazolonderivater
MA26793A1 (fr) Derives de 4-phenyl-pyrimidine.
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
ATE233253T1 (de) Chromanderivate
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
ATE234839T1 (de) 4,5-azolo-oxindole
DK1060183T3 (da) 5-deoxycytidinderivater
PT1129079E (pt) Derivados de triazina 2,4-dissubstituidos
NO20015397L (no) 1,5-Benzodiazepin-derivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application